Evidence map›Paper›PMID 33628487›Full record

ArticleCardiology research and practice2021

Clinical Phenotypes and Age-Related Differences in Presentation, Treatment, and Outcome of Heart Failure with Preserved Ejection Fraction: A Vietnamese Multicenter Research.

Ngoc-Thanh-Van Nguyen, Diep Tuan Tran, Pham Le An, Sy Van Hoang, Hoai-An Nguyen, Hoa Ngoc Chau

Open access · goldAbstract read
In one paragraph

Article in Cardiology research and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Advances in extracardiac mechanisms for heart failure with preserved ejection fraction.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  7. Article
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ngoc-Thanh-Van NguyenDivision of Cardiology, Internal Medicine Department, University of Medicine and Pharmacy at Ho Chi Minh city, Ho Chi Minh city 700 000, Vietnam.ORCID https://orcid.org/0000-0001-7007-1339
Diep Tuan TranUniversity of Medicine and Pharmacy at Ho Chi Minh city, Ho Chi Minh city 700 000, Vietnam.ORCID https://orcid.org/0000-0002-3355-7951
Pham Le AnFamily Physician Training Center, University of Medicine and Pharmacy at Ho Chi Minh city, Ho Chi Minh city 700 000, Vietnam.ORCID https://orcid.org/0000-0003-1186-0543
Sy Van HoangDivision of Cardiology, Internal Medicine Department, University of Medicine and Pharmacy at Ho Chi Minh city, Ho Chi Minh city 700 000, Vietnam.ORCID https://orcid.org/0000-0002-3984-648X
Hoai-An NguyenUniversity of Medicine and Pharmacy at Ho Chi Minh city, Ho Chi Minh city 700 000, Vietnam.ORCID https://orcid.org/0000-0001-5345-2957
Hoa Ngoc ChauDivision of Cardiology, Internal Medicine Department, University of Medicine and Pharmacy at Ho Chi Minh city, Ho Chi Minh city 700 000, Vietnam.ORCID https://orcid.org/0000-0002-2931-0737
University of Medicine and Pharmacy at Ho Chi Minh City · VNCho Ray Hospital · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeart failure with preserved ejection fraction (HFpEF) is a rising health problem with heterogeneous presentation and no evidence-based treatment. While Southeast Asia reported the highest mortality and morbidity among Asian population, little is known about the Vietnamese population, including patient characteristics, prescribing pattern and mortality rate.

methodsWe conducted an observational study on 477 patients diagnosed with HFpEF from seven hospitals in Southern Vietnam from January 2019 to December 2019.

resultsMean age was 67.6 (40.9% < 65 years). 62.3% were female. 82.4% were diagnosed within 5 years. Dyspnea, congestion, and hypoperfusion on admission were noted in 63.9%, 48.8%, and 4.6% of the patients, respectively. Median ejection fraction was 63%. Valvular heart disease (VHD) was the leading cause of heart failure (35.9%). 78.6% had at least two comorbidities, mostly hypertension (68.6%). 30.6% of the patients were hospitalized, with a median stay of 7.0 (4.0-10.0) days and inhospital mortality of 4.8%. Older patients (≥65 years) were more likely to be females (OR = 1.52); had multimorbid conditions (OR = 3.14), including hypertension (OR = 4.28), diabetes (OR = 1.73), coronary artery disease (CAD) (OR = 2.50), dyslipidemia (OR = 1.94), and chronic kidney disease (OR = 2.44); and were more frequently prescribed statin (OR = 3.15). Younger individuals (<65 years) were associated with higher mineralocorticoid antagonist uptake (OR = 0.52) and VHD (OR = 0,40). Prescription rate for renin-angiotensin-aldosterone system inhibitor, beta blocker, mineralocorticoid antagonist, and loop diuretic was 72.5%, 59.1%, 43.0%, and 60.6%, respectively. Four phenotypes were identified, including the lean/elderly/multimorbid; congestive/metabolic; CAD-induced; and younger/atrial fibrillation (AF)/VHD. The novel phenotype "younger/AF/VHD" exhibited high symptom burden and poor functional capacity despite being the youngest and least multimorbid. The "lean/elderly/multimorbid" phenotype demonstrated the highest symptom severity and inhospital mortality.

conclusionsOur research highlights a younger, predominantly female population with high disease burden. The four novelly identified phenotypes provide contemporary and pragmatic insights into a phenotype-guided approach, exclusively targeting the Vietnamese population.

Identifiers

PMID33628487
PMCPMC7884182
OpenAlexW3119565593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.